Afuco™ Anti-Human IL17RB ADCC Therapeutic Antibody, ADCC Enhanced

Anti-IL17RB ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody which bind interleukin-17 receptor B may be useful in therapy, such as the treatment of asthma, ulcerative colitis or Crohn's disease.
Supplier Creative Biolabs
Product # AFC-385CL
Pricing Inquiry
Host Mouse
Target IL17RB
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Avoid multiple freeze/thaw cycles.
Feedback